Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data.

Diabetes Metab Syndr Obes · 2020 · PMC7035886 · PMID 32110076

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The baseline bodyweight (mean of 95.8 kg) was lowered by 5.6 kg (semaglutide) and 1.9 kg (exenatide ER) respectively, giving an ETD −3.78 kg [95% CI −4.58, −2.98] which was highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.